Epithelioid fibrous histiocytoma: three diagnostically challenging cases with novel ALK gene fusions, unusual storiform growth pattern, and a prominent spindled morphology

Virchows Arch. 2022 Nov;481(5):751-757. doi: 10.1007/s00428-022-03418-0. Epub 2022 Sep 29.

Abstract

Epithelioid fibrous histiocytoma (EFH) is a distinctive cutaneous neoplasm with a relatively variable morphological appearance. Recently, it has been shown that this tumor is molecularly characterized by ALK gene fusions. We report three EFHs with unusual histological presentation represented by a prominent/predominant spindle cell proliferation arranged in a variably storiform/whirling architectural pattern with or without stromal sclerosis. One of the cases closely resembled cellular fibrous histiocytoma. All three cases were immunohistochemically ALK-positive and were analyzed for ALK gene rearrangements using a next-generation sequencing-based assay (FusionPlex Sarcoma Kit, ArcherDx). Three novel fusions, namely AP3D1::ALK, COL1A::ALK, and LRRFIP2::ALK, were detected and further confirmed by FISH in all 3 cases and RT-PCR in 1 case. All patients were elderly (62-63 years) and presented with a solitary polypoid lesion on the extremities. The awareness of these morphological variants is important since it entertains a wide and slightly different differential diagnosis than conventional EFH. We also presented evidence that a clear separation of EFH from BFH in all cases may not be as straightforward as previously thought. The consistent ALK immunoexpression and the continually expanding scale of ALK gene rearrangements provide a useful tool to distinguish EFH from its histologic mimics.

Keywords: ALK fusion; Epithelioid fibrous histiocytoma; Spindle cell; Storiform; Stromal sclerosis.

MeSH terms

  • Gene Fusion
  • Histiocytoma, Benign Fibrous* / diagnosis
  • Histiocytoma, Benign Fibrous* / genetics
  • Histiocytoma, Benign Fibrous* / pathology
  • Humans
  • Middle Aged
  • Receptor Protein-Tyrosine Kinases / genetics
  • Sarcoma* / pathology
  • Soft Tissue Neoplasms* / pathology

Substances

  • Receptor Protein-Tyrosine Kinases
  • ALK protein, human